Prevailing Practices in Ototoxicity Monitoring in Individuals With Head and Neck Cancer Undergoing Radiotherapy and Chemoradiotherapy: A Scoping Review.

Publisher: American Speech-Language-Hearing Association Country of Publication: United States NLM ID: 9114917 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-9137 (Electronic) Linking ISSN: 10590889 NLM ISO Abbreviation: Am J Audiol Subsets: MEDLINE

Original Publication: Rockville, MD : American Speech-Language-Hearing Association, c1991-

Head and Neck Neoplasms*/radiotherapy ; Head and Neck Neoplasms*/therapy ; Ototoxicity*/etiology ; Chemoradiotherapy*/adverse effects; Humans ; Radiotherapy/adverse effects ; Hearing Loss/chemically induced

Purpose: The aim of the current scoping review is to identify the studies reporting ototoxicity monitoring in individuals with head and neck cancer (HNC) undergoing radiation therapy and/or chemoradiation therapy across the world. The specific objectives were to identify and report the test protocol used, identify the most common timeline of follow-up, and identify barriers and facilitators influencing the implementation of the monitoring program.
Method: A comprehensive search was conducted across six electronic databases, including PubMed, Embase, Web of Science, Scopus, Google Scholar, and ProQuest. The scoping review method adhered to relevant guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) and frameworks. The database search was carried out by two independent researchers, and studies were selected based on specific inclusion and exclusion criteria.
Results: This scoping review identified 13 studies that fulfilled the inclusion criteria of this study. Only one study reported findings from the perspective of ototoxicity monitoring. Another study explicitly mentioned that ototoxicity monitoring was a standard of care in their hospital. Only one study reported using the relevant guidelines for monitoring ototoxicity. Specialized tests such as high-frequency audiometry, distortion product otoacoustic emissions, and vestibular tests were rarely used. Ototoxicity monitoring was influenced by awareness-related factors, technical factors, treatment-related factors, and organizational factors.
Conclusions: Research on ototoxicity monitoring programs is in its early stages, highlighting the need for standardized practices and multidisciplinary collaboration to enhance health care services for HNC patients. A standardized approach, improved awareness, and the incorporation of patient perspectives are crucial to enhancing ototoxicity monitoring in HNC patients.

Date Created: 20240725 Date Completed: 20240903 Latest Revision: 20240903

20240904

10.1044/2024_AJA-24-00028

39052439